REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,045,935 | -29.7% | 963,029 | +55.2% | 0.01% | -27.3% |
| Q2 2023 | $15,704,564 | +1459.7% | 620,489 | +1884.9% | 0.01% | +1000.0% |
| Q1 2023 | $1,006,884 | +57.8% | 31,260 | -9.6% | 0.00% | – |
| Q4 2022 | $638,088 | +27.1% | 34,566 | +85.8% | 0.00% | – |
| Q3 2022 | $502,000 | +92.3% | 18,603 | -1.5% | 0.00% | – |
| Q2 2022 | $261,000 | +4.0% | 18,893 | +47.0% | 0.00% | – |
| Q1 2022 | $251,000 | +28.7% | 12,850 | +7.6% | 0.00% | – |
| Q4 2021 | $195,000 | -99.0% | 11,937 | -98.3% | 0.00% | -100.0% |
| Q3 2021 | $19,598,000 | -2.6% | 703,443 | +3.7% | 0.01% | 0.0% |
| Q2 2021 | $20,115,000 | +31.3% | 678,631 | +23.8% | 0.01% | +18.2% |
| Q1 2021 | $15,324,000 | +24.6% | 548,293 | +26.4% | 0.01% | +22.2% |
| Q4 2020 | $12,294,000 | -13.9% | 433,778 | -23.6% | 0.01% | -25.0% |
| Q3 2020 | $14,276,000 | +3.5% | 567,845 | +0.5% | 0.01% | 0.0% |
| Q2 2020 | $13,792,000 | +131.1% | 564,758 | +40.1% | 0.01% | +71.4% |
| Q1 2020 | $5,967,000 | -11.7% | 403,157 | -3.2% | 0.01% | +16.7% |
| Q4 2019 | $6,761,000 | +60.8% | 416,566 | +28.8% | 0.01% | +50.0% |
| Q3 2019 | $4,204,000 | +45.0% | 323,353 | +44.6% | 0.00% | +33.3% |
| Q2 2019 | $2,900,000 | +61.0% | 223,565 | +95.6% | 0.00% | +50.0% |
| Q1 2019 | $1,801,000 | -21.6% | 114,268 | +0.1% | 0.00% | 0.0% |
| Q4 2018 | $2,297,000 | -27.9% | 114,101 | -11.0% | 0.00% | -33.3% |
| Q3 2018 | $3,184,000 | -7.9% | 128,144 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $3,456,000 | -11.0% | 125,908 | -0.1% | 0.00% | -25.0% |
| Q1 2018 | $3,881,000 | -14.0% | 126,020 | -0.1% | 0.00% | 0.0% |
| Q4 2017 | $4,511,000 | +109.7% | 126,180 | +61.6% | 0.00% | +100.0% |
| Q3 2017 | $2,151,000 | +0.0% | 78,059 | -4.1% | 0.00% | 0.0% |
| Q2 2017 | $2,150,000 | +27.1% | 81,434 | +0.1% | 0.00% | 0.0% |
| Q1 2017 | $1,692,000 | +0.7% | 81,351 | +0.2% | 0.00% | 0.0% |
| Q4 2016 | $1,681,000 | +29.0% | 81,213 | +1.1% | 0.00% | 0.0% |
| Q3 2016 | $1,303,000 | +19.9% | 80,352 | +0.5% | 0.00% | 0.0% |
| Q2 2016 | $1,087,000 | -23.4% | 79,967 | -1.6% | 0.00% | 0.0% |
| Q1 2016 | $1,419,000 | -49.2% | 81,272 | -0.6% | 0.00% | -50.0% |
| Q4 2015 | $2,793,000 | +19.9% | 81,748 | +4.4% | 0.00% | 0.0% |
| Q3 2015 | $2,329,000 | -5.1% | 78,267 | +2.0% | 0.00% | 0.0% |
| Q2 2015 | $2,455,000 | +67.8% | 76,765 | +8.7% | 0.00% | +100.0% |
| Q1 2015 | $1,463,000 | +19.2% | 70,640 | -2.5% | 0.00% | 0.0% |
| Q4 2014 | $1,227,000 | -12.6% | 72,438 | -0.2% | 0.00% | 0.0% |
| Q3 2014 | $1,404,000 | -38.4% | 72,616 | +8.3% | 0.00% | -50.0% |
| Q2 2014 | $2,279,000 | +20.6% | 67,035 | +11.7% | 0.00% | +33.3% |
| Q1 2014 | $1,890,000 | – | 60,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |